vs
STANDARD BIOTOOLS INC.（LAB）与TAYLOR DEVICES, INC.（TAYD）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是TAYLOR DEVICES, INC.的1.7倍（$19.6M vs $11.6M），TAYLOR DEVICES, INC.净利率更高（17.3% vs -177.4%，领先194.7%），TAYLOR DEVICES, INC.同比增速更快（35.7% vs -11.5%），TAYLOR DEVICES, INC.自由现金流更多（$4.4M vs $-23.1M），过去两年TAYLOR DEVICES, INC.的营收复合增速更高（-2.7% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
泰勒公司是一家私人控股的印刷与传播服务企业，1975年由商人格伦·泰勒创立，总部位于明尼苏达州北曼卡托。公司在全球范围内拥有超过90个运营网点，雇佣员工近万人，在美国数十个州及全球多个国家都开展印刷业务。
LAB vs TAYD — 直观对比
营收规模更大
LAB
是对方的1.7倍
$11.6M
营收增速更快
TAYD
高出47.2%
-11.5%
净利率更高
TAYD
高出194.7%
-177.4%
自由现金流更多
TAYD
多$27.5M
$-23.1M
两年增速更快
TAYD
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $11.6M |
| 净利润 | $-34.7M | $2.0M |
| 毛利率 | 48.5% | 47.0% |
| 营业利润率 | -168.5% | 19.2% |
| 净利率 | -177.4% | 17.3% |
| 营收同比 | -11.5% | 35.7% |
| 净利润同比 | -28.8% | 90.2% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABTAYD
| Q4 25 | — | $11.6M | ||
| Q3 25 | $19.6M | $9.9M | ||
| Q2 25 | $21.8M | $15.6M | ||
| Q1 25 | $40.8M | $10.6M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | $22.1M | $11.6M | ||
| Q2 24 | $22.5M | $12.1M | ||
| Q1 24 | $45.5M | $12.3M |
净利润LABTAYD
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-34.7M | $2.2M | ||
| Q2 25 | $-33.5M | $3.7M | ||
| Q1 25 | $-26.0M | $2.0M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-26.9M | $2.7M | ||
| Q2 24 | $-45.7M | $2.5M | ||
| Q1 24 | $-32.2M | $2.7M |
毛利率LABTAYD
| Q4 25 | — | 47.0% | ||
| Q3 25 | 48.5% | 44.8% | ||
| Q2 25 | 48.8% | 48.6% | ||
| Q1 25 | 48.4% | 42.9% | ||
| Q4 24 | — | 45.5% | ||
| Q3 24 | 54.9% | 47.4% | ||
| Q2 24 | 46.1% | 48.8% | ||
| Q1 24 | 53.1% | 46.9% |
营业利润率LABTAYD
| Q4 25 | — | 19.2% | ||
| Q3 25 | -168.5% | 22.6% | ||
| Q2 25 | -118.1% | 24.2% | ||
| Q1 25 | -80.8% | 19.1% | ||
| Q4 24 | — | 11.0% | ||
| Q3 24 | -120.9% | 25.0% | ||
| Q2 24 | -134.5% | 20.8% | ||
| Q1 24 | -132.2% | 24.4% |
净利率LABTAYD
| Q4 25 | — | 17.3% | ||
| Q3 25 | -177.4% | 22.1% | ||
| Q2 25 | -153.7% | 23.7% | ||
| Q1 25 | -63.8% | 19.0% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | -122.0% | 23.0% | ||
| Q2 24 | -203.3% | 20.5% | ||
| Q1 24 | -70.6% | 22.0% |
每股收益（稀释后）LABTAYD
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-0.27 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $40.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $67.1M |
| 总资产 | $539.6M | $72.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABTAYD
| Q4 25 | — | $40.7M | ||
| Q3 25 | $129.4M | $36.3M | ||
| Q2 25 | $158.6M | $36.0M | ||
| Q1 25 | $150.9M | $35.4M | ||
| Q4 24 | — | $26.6M | ||
| Q3 24 | $210.6M | $27.1M | ||
| Q2 24 | $269.8M | $31.0M | ||
| Q1 24 | $287.1M | $24.6M |
总债务LABTAYD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABTAYD
| Q4 25 | — | $67.1M | ||
| Q3 25 | $399.7M | $64.3M | ||
| Q2 25 | $424.5M | $62.0M | ||
| Q1 25 | $454.6M | $57.8M | ||
| Q4 24 | — | $55.8M | ||
| Q3 24 | $489.3M | $53.9M | ||
| Q2 24 | $510.3M | $51.2M | ||
| Q1 24 | $577.3M | $47.8M |
总资产LABTAYD
| Q4 25 | — | $72.8M | ||
| Q3 25 | $539.6M | $70.3M | ||
| Q2 25 | $557.0M | $71.6M | ||
| Q1 25 | $579.6M | $70.1M | ||
| Q4 24 | — | $62.9M | ||
| Q3 24 | $681.5M | $61.9M | ||
| Q2 24 | $708.7M | $63.1M | ||
| Q1 24 | $777.7M | $54.8M |
负债/权益比LABTAYD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $5.7M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $4.4M |
| 自由现金流率自由现金流/营收 | -118.1% | 38.3% |
| 资本支出强度资本支出/营收 | 4.5% | 11.3% |
| 现金转化率经营现金流/净利润 | — | 2.86× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $14.1M |
8季度趋势，按日历期对齐
经营现金流LABTAYD
| Q4 25 | — | $5.7M | ||
| Q3 25 | $-22.2M | $483.6K | ||
| Q2 25 | $-20.7M | $1.9M | ||
| Q1 25 | $-30.3M | $9.0M | ||
| Q4 24 | — | $103.1K | ||
| Q3 24 | $-27.9M | $-3.6M | ||
| Q2 24 | $-39.0M | $6.5M | ||
| Q1 24 | $-62.5M | $-685.0K |
自由现金流LABTAYD
| Q4 25 | — | $4.4M | ||
| Q3 25 | $-23.1M | $298.6K | ||
| Q2 25 | $-22.6M | $491.3K | ||
| Q1 25 | $-35.3M | $8.8M | ||
| Q4 24 | — | $-620.5K | ||
| Q3 24 | $-30.1M | $-3.8M | ||
| Q2 24 | $-41.0M | $6.1M | ||
| Q1 24 | $-63.3M | $-895.5K |
自由现金流率LABTAYD
| Q4 25 | — | 38.3% | ||
| Q3 25 | -118.1% | 3.0% | ||
| Q2 25 | -103.6% | 3.2% | ||
| Q1 25 | -86.6% | 83.6% | ||
| Q4 24 | — | -7.3% | ||
| Q3 24 | -136.4% | -33.0% | ||
| Q2 24 | -182.2% | 51.0% | ||
| Q1 24 | -138.9% | -7.3% |
资本支出强度LABTAYD
| Q4 25 | — | 11.3% | ||
| Q3 25 | 4.5% | 1.9% | ||
| Q2 25 | 8.7% | 9.3% | ||
| Q1 25 | 12.4% | 1.8% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | 10.2% | 2.1% | ||
| Q2 24 | 8.6% | 3.3% | ||
| Q1 24 | 1.7% | 1.7% |
现金转化率LABTAYD
| Q4 25 | — | 2.86× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 4.51× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | -1.35× | ||
| Q2 24 | — | 2.65× | ||
| Q1 24 | — | -0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
TAYD
暂无分部数据
